Purpose of the Core As the central coordinating entity for the UAB CFAR, the Administrative Core serves to translate the mission of the CFAR into action. The CFAR is designated a University-wide Center within the Institution and as such is responsible directly to the Vice President for Research and Economic Development (R Marchase). CFAR has departmental status and is governed by established CFAR Policies and Procedures (See Appendix 1). The mission of the Center is to achieve improved diagnosis, treatment and prevention of AIDS by facilitating the development of new knowledge from multidisciplinary research in service to the pillars of the CFAR scientific mission of prevention, drug discovery, pathogenesis and understanding the natural history of HIV in the treatment era. Ensuring service to these 4 overarching pillars of scientific research (depicted on red ribbon diagram, left) unifies our purpose and aligns our goals with those of the National AIDS Strategy and the HIV scientific community. The Center fulfills this mission by enhancing and extending the effectiveness of groups of investigators conducting AIDS-related research and by promoting collaboration and interaction between participating investigators. The Administrative Core ensures the necessary infrastructure and oversight to support 8 research core facilities with specialized equipment, trained personnel and access to developmental research funds for over 200 members in the UAB research community. Annual strategic planning processes guide future directions for the CFAR and ensures that the Center is responsive to the needs of its membership. Interdisciplinary Research Groups (IRGs) are employed as a critical management tool to create new, dynamic programs that align emerging trends in the HIV research community to our stated mission, in essence operationalizing our strategic plan.

National Institute of Health (NIH)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Alabama Birmingham
United States
Zip Code
Bateman, Allen C; Chibwesha, Carla J; Parham, Groesbeck P (2015) Minimizing verification bias in cervical cancer screening of HIV-infected women. Int J Gynaecol Obstet 128:269-70
Miller, Michelle M; Akaronu, Nnenna; Thompson, Elizabeth M et al. (2015) Modulating DNA methylation in activated CD8+ T cells inhibits regulatory T cell-induced binding of Foxp3 to the CD8+ T Cell IL-2 promoter. J Immunol 194:990-8
Mugavero, Michael J; Westfall, Andrew O; Cole, Stephen R et al. (2014) Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis 59:1471-9
Li, Jun; Hsu, Hui-Chen; Ding, Yana et al. (2014) Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis. Arthritis Rheumatol 66:2368-79
Yuan, Furong; Yosef, Nejla; Lakshmana Reddy, Chetan et al. (2014) CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome. PLoS One 9:e90463
Stevenson, Catherine; de la Rosa, Gonzalo; Anderson, Christopher S et al. (2014) Essential role of Elmo1 in Dock2-dependent lymphocyte migration. J Immunol 192:6062-70
Huijbregts, Richard P H; Michel, Katherine G; Hel, Zdenek (2014) Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs. Contraception 90:123-9
Parker, Ivana Kennedy; Roberts, Ladeidra Monet; Hansen, Laura et al. (2014) Pro-atherogenic shear stress and HIV proteins synergistically upregulate cathepsin K in endothelial cells. Ann Biomed Eng 42:1185-94
Li, Hao; Hsu, Hui-Chen; Wu, Qi et al. (2014) IL-23 promotes TCR-mediated negative selection of thymocytes through the upregulation of IL-23 receptor and ROR?t. Nat Commun 5:4259
Sarzotti-Kelsoe, Marcella; Daniell, Xiaoju; Todd, Christopher A et al. (2014) Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells. J Immunol Methods 409:147-60

Showing the most recent 10 out of 564 publications